Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
 Disease Category: Diabetes Mellitus, Type 2
Location: United States, CA

Trial Information

You may be eligible to join the EMERGE STUDY if you

  • Are between 18 and 75 years old
  • Have been taking a stable dose of pioglitazone ≥ 30 mg/day and metformin ≥ 1,500 mg/day (or the maximum tolerated dose or maximum dose specified on the label) for at least 12 months
  • Have had no treatment with insulin for longer than 1 week during the past 6 months
  • Have weighed about the same for at least 12 weeks
    • Agree to maintain you current diet and exercise habits throughout your participation in the study

If you decide to join the study, you will be asked to:

  • Take your study medication (by injection) once a week for up to 52 weeks
  • Atted up to 11 study visits during a 1-year period and participate in a follow-up telephone visit
  • Undergo study-related procedures, including:
    • Blood draws and urine samples
    • Physical examinations (including weight and waist/hip circumference measurement
    • Vital signs (blood pressure, heart rate)
    • ECG testing
    • Glucose testing
  • Monitor your glucose levels at home
  • Maintain a study diary

To find out more and to see if you qualify, please call:

Diablo Clinical Research
2255 Ygnacio Valley Rd., Suite M
Walnut Creek, CA 94598
Phone: 925-930-7267
Fax: 925-930-7392
Email: studies@diabloclinical.com

View Map

Research Center Information: Diablo Clinical Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.